Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jul 01, 2004

Mylan's NDA for Nebivolol Accepted for FDA Review

Jun 30, 2004

Mylan Submits a Supplement to Its Citizens Petition Regarding Authorized Generics to the FDA

Jun 29, 2004

Mylan Names Margaret McKenna Chief Business Development Officer

Jun 28, 2004

Mylan Nominates Rod Piatt to its Board of Directors

Jun 25, 2004

Mylan Receives $37.5 Million and Settles All Outstanding Disputes With Schwarz Pharma's KUDCo and Related Parties

Jun 24, 2004

Mylan Receives FDA Approval for Levothyroxine Sodium Tablets

Jun 23, 2004

Mylan Sues FDA for Injunction Against Fentanyl Ruling

Jun 22, 2004

Mylan Laboratories Appoints Michael Marquard President of Mylan Bertek Pharmaceuticals

Jun 15, 2004

Mylan Announces Name Change for its Branded Products Subsidiary to Mylan Bertek

Jun 14, 2004

Mylan Declares Quarterly Cash Dividend

Pagination

First page
Previous page
…
Page 115
Page 116
Page 117
Page 118
Current page 119
Page 120
Page 121
Page 122
Page 123
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.